Merck’s New COVID-19 Pill: Who Can Take It & When Will It Be Available in India?InformationBy Vidya Raja05 Oct 2021 15:30 ISTIn Phase 3 of its clinical trial, Merck & Co's anti-COVID Molnupiravir may reach Indian markets soon. Here's what you need to know about its cost, side-effects and treatment.Read More
/english-betterindia/media/post_attachments/uploads/2021/10/image-43.jpg)